Topic

Cigna

A collection of 1335 issues

Myths vs. Facts: Getting Pombiliti (cipaglucosidase alfa-atga) Covered by Cigna in Florida

Answer Box: Getting Pombiliti Covered by Cigna in Florida Cigna requires prior authorization for Pombiliti (cipaglucosidase alfa-atga) in Florida. Most denials stem from documentation gaps, not coverage exclusions. Fastest path to approval: Submit complete prior authorization through Cigna's electronic system with genetic confirmation, failed ERT documentation, and specialist

Getting Zanzalintinib (XL092) Covered by Cigna in Pennsylvania: Complete Coding and Appeals Guide

Answer Box: Your Path to Coverage Zanzalintinib (XL092) is an investigational cancer drug requiring special approval from Cigna. In Pennsylvania, you'll need: (1) Your doctor submits a prior authorization with clinical trial documentation or compassionate use approval from Exelixis, (2) if denied, file internal appeals within 180 days,

How to Get Photrexa Covered by Cigna in Ohio: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Photrexa Covered by Cigna in Ohio Yes, Cigna covers Photrexa (riboflavin ophthalmic solution) for FDA-approved epithelium-off corneal cross-linking in progressive keratoconus. Your ophthalmologist must submit prior authorization through Cigna's provider portal with documented progression evidence (Kmax increase ≥1.0D, pachymetry thinning, topography changes over 3-12

Getting Pombiliti (Cipaglucosidase Alfa) Covered by Cigna in Pennsylvania: Prior Authorization, Appeals, and Cost-Saving Strategies

Quick Answer: Getting Pombiliti Covered by Cigna in Pennsylvania Cigna requires prior authorization for Pombiliti (cipaglucosidase alfa-atga) and places it on Tier 5 specialty formulary. First step: Have your prescriber submit PA through CoverMyMeds or ExpressPAth with genetic confirmation of Pompe disease and documentation that you're not improving

Getting Hetlioz (Tasimelteon) Covered by Cigna in Ohio: Complete PA Guide and Appeals Process

Quick Answer: Getting Hetlioz (Tasimelteon) Covered by Cigna in Ohio Cigna requires prior authorization for Hetlioz (tasimelteon) for both Non-24-Hour Sleep-Wake Disorder and Smith-Magenis Syndrome. The fastest path to approval: (1) Ensure your sleep specialist documents diagnosis with ICD-10 code G47.24, (2) Complete step therapy with ramelteon and a